New drug SON-DP enters human testing for advanced cancers
Disease control
Recruiting now
This early-phase study tests a new drug, SON-DP, in 96 adults with advanced solid tumors, including liver and gastric cancers. The main goals are to check safety, find the best dose, and see if the drug can shrink tumors. Participants must have a measurable tumor and be between 1…
Phase: PHASE1 • Sponsor: Qurgen Inc. • Aim: Disease control
Last updated May 15, 2026 11:53 UTC